Why Kimberly-Clark (KMB) Stock Is Nosediving

Shares of household products company Kimberly-Clark (NYSE:KMB) fell 12.6% in the afternoon session after it announced a deal to acquire consumer health company Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion. The deal involved both cash and stock, which meant that the ownership stake for existing Kimberly-Clark shareholders was set to be diluted; they were expected to own about 54% of the combined company. The markets harsh reaction also seemed tied to Kenvues

Kenvue Inc stock hits 52-week low at 16.06 USD By Investing.com

Kenvue Inc stock hits 52-week low at 16.06 USD

Kenvue bounces after Trump’s Tylenol remarks spark sell-off

After a bruising session on Monday, Kenvue Inc (NYSE:KVUE) shares staged a 6% rebound in premarket trade on Tuesday, clawing back much of the previous day’s...

Kenvue takes a $1.4bn Tylenol hit

Kenvue Inc (NYSE:KVUE) shares dropped 4% at the open on Monday, erasing about $1.4 billion in market value, after a report that Trump administration...

Heres How You Can Earn $100 In Passive Income By Investing In Kenvue Stock

Kenvue Inc. (NYSE:KVUE) is a consumer health company that offers well-known brands in categories like pain management, skin and beauty, oral care, and cough, cold, and allergy care, including brands like Tylenol, Listerine, and Neutrogena. It will ...

Kenvue misses Q2 sales estimates, cuts 2025 profit forecast

Kenvue Inc (NYSE:KVUE) reported second quarter sales below Wall Street expectations, while also downwardly revising its full-year profit forecast. The...

Kenvue takeover speculation heats up ahead of M&A window

Kenvue Inc (NYSE:KVUE) is again at the center of takeover speculation as the August expiration of its post–spin-off tax agreement with Johnson & Johnson...

Kenvue considering sale of skin and beauty brands to streamline portfolio: report

Kenvue Inc (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson (NYSE:JNJ) in 2023, is considering selling a selection of its smaller...

Kenvue stock climbs as second quarter comes in ahead of forecasts

Consumer brands firm Kenvue Inc (NYSE:KVUE) traded on the front foot in Thursday’s early deals, as its second quarter beat expectations (but, fell short in...

Kenvue, Inc. (KVUE) Q4 2024 Earnings Call Transcript

Kenvue Inc. 2024 Q3 - Results - Earnings Call Presentation

Tylenol maker Kenvue hails efficiency gains as activist Starboard watches on

Kenvue Inc (NYSE:KVUE), the maker of Listerine, Tylenol, Aveeno and Band-Aid, reported slightly lower sales than expected but earnings were just above Wall...

Kenvue gains on reports activist investor Starboard Value has taken ‘sizeable’ stake

Kenvue Inc (NYSE:KVUE) shares moved more than 6% higher on reports activist investor Starboard Value has taken a stake in the consumer goods company and is...

Neuer Druck auf Kenvue: Starboard beteiligt sich und fordert Kurskorrektur

Der aktivistische Investor Starboard Value hat laut mit der Angelegenheit vertrauten Personen eine beträchtliche Beteiligung an Kenvue Inc. (NYSE: KVUE) erworben. Bei Kenvue handelt es sich um einen...

Kenvue Inc. (KVUE) Q2 2024 Earnings Call Transcript

Kenvue Inc. 2024 Q2 - Results - Earnings Call Presentation

Kenvue stock up 9% after earnings beat; consumer health stars

Shares in Kenvue Inc (NYSE:KVUE) were up 9% in pre-market trading after the company exceeded Wall Streets expectations for second-quarter profit and...

Kenvue Inc. (KVUE) Q1 2024 Earnings Call Transcript

Kenvue shares rise on first quarter earnings beat

Kenvue Inc (NYSE:KVUE) shares moved higher after the Tylenol-maker posted better-than-expected first quarter earnings on Tuesday. Shares of the Johnson &...

Kenvue Inc. declares $0.20 dividend

Neutrogena Is Closing Its Los Angeles Office and Laying Off Staff

Neutrogena is permanently closing its Los Angeles office as parent Kenvue Inc. consolidates operations to New Jersey.